Bioton (WAR:BIO) Inventories, Finished Goods : zł0.0 Mil (As of Mar. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Bioton Inventories, Finished Goods?

Bioton's quarterly finished goods increased from Sep. 2023 (zł0.0 Mil) to Dec. 2023 (zł43.7 Mil) but then declined from Dec. 2023 (zł43.7 Mil) to Mar. 2024 (zł0.0 Mil).

Bioton's annual finished goods declined from Dec. 2021 (zł40.2 Mil) to Dec. 2022 (zł29.0 Mil) but then increased from Dec. 2022 (zł29.0 Mil) to Dec. 2023 (zł43.7 Mil).

Bioton Inventories, Finished Goods Historical Data

The historical data trend for Bioton's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioton Inventories, Finished Goods Chart

Bioton Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventories, Finished Goods

Get a 7-Day Free Trial

23.77

30.61

40.23

29.01

43.73

Bioton Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Inventories, Finished Goods	Get a 7-Day Free Trial															-	-	-	43.73	-

Bioton Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Bioton (WAR:BIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioton SA (WAR:BIO) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

7U5:Germany

Address

Ul. Staro?ci?ska 5, Warszawa, POL, 02-516

Website

http://www.bioton.pl

Bioton SA is a Poland based company engaged in the principal business activity of manufacturing medicines and pharmaceutical preparations and production of pharmaceutical substances. The products of the company include recombinant human insulin in pharmaceutical substance form and as preparations for injections; glimepiride, an oral hypoglycemic drug; and metformin, an oral hypoglycemic drug. Its products line focuses on diet supplements, products for particular nutritional uses and cosmetics dedicated to patients with certain health problems. The group operates in Poland and internationally, of which majority of the revenue is derived from Poland.